| Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1960 | 2016 |
| Adverse effects of topical glucocorticosteroids UR Hengge, T Ruzicka, RA Schwartz, MJ Cork Journal of the American Academy of Dermatology 54 (1), 1-15, 2006 | 1362 | 2006 |
| Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity LC Tsoi, SL Spain, J Knight, E Ellinghaus, PE Stuart, F Capon, J Ding, ... Nature genetics 44 (12), 1341-1348, 2012 | 1120 | 2012 |
| Genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 A Strange, F Capon, CCA Spencer, J Knight, ME Weale, MH Allen, ... Nature genetics 42 (11), 985, 2010 | 1051 | 2010 |
| Epidermal barrier dysfunction in atopic dermatitis MJ Cork, S Danby, Y Vasilopoulos, M Moustafa, A MacGowan, ... Textbook of Atopic Dermatitis, 47-70, 2008 | 1050 | 2008 |
| Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention EL Simpson, JR Chalmers, JM Hanifin, KS Thomas, MJ Cork, ... Journal of Allergy and Clinical Immunology 134 (4), 818-823, 2014 | 924 | 2014 |
| New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene–environment interactions MJ Cork, DA Robinson, Y Vasilopoulos, A Ferguson, M Moustafa, ... Journal of Allergy and Clinical Immunology 118 (1), 3-21, 2006 | 767 | 2006 |
| Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2) A Wollenberg, A Blauvelt, E Guttman‐Yassky, M Worm, C Lynde, ... British Journal of Dermatology 184 (3), 437-449, 2021 | 518 | 2021 |
| Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment … M de Bruin‐Weller, D Thaçi, CH Smith, K Reich, MJ Cork, A Radin, ... British Journal of Dermatology 178 (5), 1083-1101, 2018 | 510 | 2018 |
| UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016 D Creamer, SA Walsh, P Dziewulski, LS Exton, HY Lee, JKG Dart, ... British Journal of Dermatology 174 (6), 1194-1227, 2016 | 483 | 2016 |
| Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo … EL Simpson, R Sinclair, S Forman, A Wollenberg, R Aschoff, M Cork, ... The Lancet 396 (10246), 255-266, 2020 | 442 | 2020 |
| Conjunctivitis in dupilumab clinical trials B Akinlade, E Guttman‐Yassky, M de Bruin‐Weller, EL Simpson, ... British Journal of Dermatology 181 (3), 459-473, 2019 | 422 | 2019 |
| ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children A Wollenberg, S Christen‐Zäch, A Taieb, C Paul, JP Thyssen, ... Journal of the European Academy of Dermatology and Venereology 34 (12), 2717 …, 2020 | 412 | 2020 |
| Topical treatments for chronic plaque psoriasis AR Mason, J Mason, M Cork, G Dooley, H Hancock Cochrane Database of Systematic Reviews, 2013 | 397 | 2013 |
| Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context H Chen, LM Wilkins, N Aziz, C Cannings, DH Wyllie, C Bingle, J Rogus, ... Human molecular genetics 15 (4), 519-529, 2006 | 392 | 2006 |
| Cyclosporin for severe childhood atopic dermatitis: short course versuscontinuous therapy JI Harper, I Ahmed, G Barclay, M Lacour, P Hoeger, MJ Cork, AY Finlay, ... British Journal of Dermatology 142 (1), 52-58, 2000 | 387 | 2000 |
| Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo … AS Paller, EC Siegfried, D Thaçi, A Wollenberg, MJ Cork, PD Arkwright, ... Journal of the American Academy of Dermatology 83 (5), 1282-1293, 2020 | 371 | 2020 |
| Interleukin–1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus AIF Blakemore, JK Tarlow, M J. Cork, C Gordon, P Emery, GW Duff Arthritis & Rheumatism: Official Journal of the American College of …, 1994 | 367 | 1994 |
| British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018 FM Lewis, FM Tatnall, SS Velangi, CB Bunker, A Kumar, F Brackenbury, ... British Journal of Dermatology 178 (4), 839-853, 2018 | 358 | 2018 |
| Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist … MJ Cork, J Britton, L Butler, S Young, R Murphy, SG Keohane British Journal of Dermatology 149 (3), 582-589, 2003 | 356 | 2003 |
Eric SimpsonFrances J. Storrs Medical Dermatology Professor, Dermatology, OHSUVerified email at ohsu.edu
